Adamas Pharmaceuticals Sharply Higher Off New Outperform Rating

Adamas Pharmaceuticals Inc ADMS shares are trading higher by $4.50 (22 percent) at $24.01 in Monday's session.

Before the open, Evercore ISI Group initiated coverage on the company with an Outperform rating and a $85.00 price target.

After a higher open, Adamas had nearly a $1.00 drop to $22.10 before continuing its move higher. The ensuing rally took the stock to $24.55, but has fallen back under $24.00.

That marks the highest level for the stock since Jan. 19, 2016, when it peaked at $25.89.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: TechnicalsIntraday UpdateMoversTrading Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!